Leukocyte Disorders D007960

Diseases [C] » Hemic and Lymphatic Diseases [C15] » Hematologic Diseases » Leukocyte Disorders

Description

Disordered formation of various types of leukocytes or an abnormal accumulation or deficiency of these cells.   MeSH

Subtype Terms (7)

Eosinophilia
7 drugs (6 approved, 1 experimental)

Infectious Mononucleosis
7 drugs (4 approved, 3 experimental)

Leukocytosis
1 experimental drug

Leukopenia
6 drugs (4 approved, 2 experimental)

Leukostasis
 

Pelger-Huet Anomaly
 


Phase 4 Indicated Drugs (1)

Phase 2 Indicated Drugs (1)

Other Experimental Indicated Drugs (1)


Organization Involved with Phase 4 Indications (1)

Organization Involved with Phase 2 Indications (1)

Organization Involved with Other Experimental Indications (1)

Hierarchy Tree View

UMLS Data


YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.